{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,29]],"date-time":"2026-10-29T12:36:33Z","timestamp":1793277393597,"version":"4.5.0"},"reference-count":47,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,7,2]],"date-time":"2025-07-02T00:00:00Z","timestamp":1751414400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,7,2]],"date-time":"2025-07-02T00:00:00Z","timestamp":1751414400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"name":"Lung Bioengineering and Traferox Technologies"},{"name":"Traferox technologies"},{"name":"IP licensed to Traferox Technologies"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"DOI":"10.1038\/s41598-025-06835-8","type":"journal-article","created":{"date-parts":[[2025,7,2]],"date-time":"2025-07-02T01:43:09Z","timestamp":1751420589000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":6,"title":["Permissive immunosuppression facilitates the expansion of ex vivo administered regulatory T cells in the lung allograft"],"prefix":"10.1038","volume":"15","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-5043-6046","authenticated-orcid":false,"given":"Akihiro","family":"Takahagi","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ei","family":"Miyamoto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christina","family":"Lam","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mingyao","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Betty","family":"Joe","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaomin","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David","family":"Hwang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tereza","family":"Martinu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marcelo","family":"Cypel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shaf","family":"Keshavjee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7243-556X","authenticated-orcid":false,"given":"Stephen","family":"Juvet","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,7,2]]},"reference":[{"key":"6835_CR1","doi-asserted-by":"publisher","first-page":"1170","DOI":"10.1016\/j.healun.2016.09.001","volume":"35","author":"RD Yusen","year":"2016","unstructured":"Yusen, R. D. et al. The registry of the international society for heart and lung transplantation: Thirty-third adult lung and heart-Lung transplant Report-2016; focus theme: primary diagnostic indications for transplant. J. Heart Lung Transpl. 35, 1170\u20131184. https:\/\/doi.org\/10.1016\/j.healun.2016.09.001 (2016).","journal-title":"J. Heart Lung Transpl."},{"key":"6835_CR2","doi-asserted-by":"publisher","DOI":"10.1016\/j.healun.2017.07.016","author":"DC Chambers","year":"2017","unstructured":"Chambers, D. C. et al. Focus Theme: Allograft ischemic time. J. Heart Lung Transpl. 36, 1047\u20131059. https:\/\/doi.org\/10.1016\/j.healun.2017.07.016 (2017). Thirty-fourth Adult Lung And Heart-Lung Transplantation Report-2017."},{"key":"6835_CR3","doi-asserted-by":"publisher","first-page":"354","DOI":"10.3389\/fimmu.2018.00354","volume":"9","author":"N Safinia","year":"2018","unstructured":"Safinia, N. et al. Cell therapy in organ transplantation: our experience on the clinical translation of regulatory T cells. Front. Immunol. 9, 354. https:\/\/doi.org\/10.3389\/fimmu.2018.00354 (2018).","journal-title":"Front. Immunol."},{"key":"6835_CR4","doi-asserted-by":"publisher","first-page":"1125","DOI":"10.1111\/ajt.15700","volume":"20","author":"A S\u00e1nchez-Fueyo","year":"2020","unstructured":"S\u00e1nchez-Fueyo, A. et al. Applicability, safety, and biological activity of regulatory T cell therapy in liver transplantation. Am. J. Transpl. 20, 1125\u20131136. https:\/\/doi.org\/10.1111\/ajt.15700 (2020).","journal-title":"Am. J. Transpl."},{"key":"6835_CR5","doi-asserted-by":"publisher","first-page":"432","DOI":"10.1097\/MOT.0b013e32832c58f1","volume":"14","author":"G Feng","year":"2009","unstructured":"Feng, G., Chan, T., Wood, K. J. & Bushell, A. Donor reactive regulatory T cells. Curr. Opin. Organ. Transplant. 14, 432\u2013438. https:\/\/doi.org\/10.1097\/MOT.0b013e32832c58f1 (2009).","journal-title":"Curr. Opin. Organ. Transplant."},{"key":"6835_CR6","doi-asserted-by":"publisher","first-page":"67","DOI":"10.1016\/j.surg.2007.02.014","volume":"142","author":"LY Pu","year":"2007","unstructured":"Pu, L. Y. et al. Adoptive transfusion of ex vivo donor alloantigen-stimulated CD4(+)CD25(+) regulatory T cells ameliorates rejection of DA-to-Lewis rat liver transplantation. Surgery 142, 67\u201373. https:\/\/doi.org\/10.1016\/j.surg.2007.02.014 (2007).","journal-title":"Surgery"},{"key":"6835_CR7","doi-asserted-by":"publisher","first-page":"1413","DOI":"10.1172\/jci82771","volume":"126","author":"KG MacDonald","year":"2016","unstructured":"MacDonald, K. G. et al. Alloantigen-specific regulatory T cells generated with a chimeric antigen receptor. J. Clin. Investig. 126, 1413\u20131424. https:\/\/doi.org\/10.1172\/jci82771 (2016).","journal-title":"J. Clin. Investig."},{"key":"6835_CR8","doi-asserted-by":"publisher","first-page":"917","DOI":"10.1111\/ajt.14175","volume":"17","author":"F Noyan","year":"2017","unstructured":"Noyan, F. et al. Prevention of allograft rejection by use of regulatory T cells with an MHC-Specific chimeric antigen receptor. Am. J. Transplantation: Official J. Am. Soc. Transplantation Am. Soc. Transpl. Surg. 17, 917\u2013930. https:\/\/doi.org\/10.1111\/ajt.14175 (2017).","journal-title":"Am. J. Transplantation: Official J. Am. Soc. Transplantation Am. Soc. Transpl. Surg."},{"key":"6835_CR9","doi-asserted-by":"publisher","first-page":"3449","DOI":"10.1111\/j.1600-6143.2012.04269.x","volume":"12","author":"T Akimova","year":"2012","unstructured":"Akimova, T. et al. Differing effects of Rapamycin or calcineurin inhibitor on T-regulatory cells in pediatric liver and kidney transplant recipients. Am. J. Transplantation: Official J. Am. Soc. Transplantation Am. Soc. Transpl. Surg. 12, 3449\u20133461. https:\/\/doi.org\/10.1111\/j.1600-6143.2012.04269.x (2012).","journal-title":"Am. J. Transplantation: Official J. Am. Soc. Transplantation Am. Soc. Transpl. Surg."},{"key":"6835_CR10","doi-asserted-by":"publisher","first-page":"1627","DOI":"10.1016\/S0140-6736(20)30167-7","volume":"395","author":"B Sawitzki","year":"2020","unstructured":"Sawitzki, B. et al. Regulatory cell therapy in kidney transplantation (The ONE Study): a harmonised design and analysis of seven non-randomised, single-arm, phase 1\/2A trials. Lancet 395, 1627\u20131639. https:\/\/doi.org\/10.1016\/S0140-6736(20)30167-7 (2020).","journal-title":"Lancet"},{"key":"6835_CR11","doi-asserted-by":"publisher","first-page":"535","DOI":"10.1097\/cmr.0000000000000283","volume":"26","author":"ML Diller","year":"2016","unstructured":"Diller, M. L., Kudchadkar, R. R., Delman, K. A., Lawson, D. H. & Ford, M. L. Complete response to high-dose IL-2 and enhanced IFN\u03b3\u2009+\u2009Th17: TREG ratio in a melanoma patient. Melanoma Res. 26, 535\u2013539. https:\/\/doi.org\/10.1097\/cmr.0000000000000283 (2016).","journal-title":"Melanoma Res."},{"key":"6835_CR12","doi-asserted-by":"publisher","first-page":"e35650","DOI":"10.1371\/journal.pone.0035650","volume":"7","author":"H Guan","year":"2012","unstructured":"Guan, H., Singh, N. P., Singh, U. P., Nagarkatti, P. S. & Nagarkatti, M. Resveratrol prevents endothelial cells injury in high-dose interleukin-2 therapy against melanoma. PLoS One. 7, e35650. https:\/\/doi.org\/10.1371\/journal.pone.0035650 (2012).","journal-title":"PLoS One"},{"key":"6835_CR13","doi-asserted-by":"publisher","first-page":"751","DOI":"10.1084\/jem.20082824","volume":"206","author":"KE Webster","year":"2009","unstructured":"Webster, K. E. et al. In vivo expansion of T reg cells with IL-2-mAb complexes: induction of resistance to EAE and long-term acceptance of islet allografts without immunosuppression. J. Exp. Med. 206, 751\u2013760. https:\/\/doi.org\/10.1084\/jem.20082824 (2009).","journal-title":"J. Exp. Med."},{"key":"6835_CR14","doi-asserted-by":"publisher","first-page":"13508","DOI":"10.1073\/pnas.1903165116","volume":"116","author":"N Pilat","year":"2019","unstructured":"Pilat, N. et al. Treg-mediated prolonged survival of skin allografts without immunosuppression. Proc. Natl. Acad. Sci. U S A. 116, 13508\u201313516. https:\/\/doi.org\/10.1073\/pnas.1903165116 (2019).","journal-title":"Proc. Natl. Acad. Sci. U S A"},{"key":"6835_CR15","doi-asserted-by":"publisher","first-page":"2373","DOI":"10.1002\/eji.202048875","volume":"51","author":"N Safinia","year":"2021","unstructured":"Safinia, N., Vaikunthanathan, T., Lechler, R. I., Sanchez-Fueyo, A. & Lombardi, G. Advances in liver transplantation: where are we in the pursuit of transplantation tolerance? Eur. J. Immunol. 51, 2373\u20132386. https:\/\/doi.org\/10.1002\/eji.202048875 (2021).","journal-title":"Eur. J. Immunol."},{"key":"6835_CR16","doi-asserted-by":"publisher","first-page":"1810","DOI":"10.1159\/000485818","volume":"44","author":"J Xiao","year":"2017","unstructured":"Xiao, J. et al. The IL-2\/Anti-IL-2 complex attenuates cardiac Ischaemia-Reperfusion injury through expansion of regulatory T cells. Cell. Physiol. Biochemistry: Int. J. Experimental Cell. Physiol. Biochem. Pharmacol. 44, 1810\u20131827. https:\/\/doi.org\/10.1159\/000485818 (2017).","journal-title":"Cell. Physiol. Biochemistry: Int. J. Experimental Cell. Physiol. Biochem. Pharmacol."},{"key":"6835_CR17","doi-asserted-by":"publisher","unstructured":"Wang, H. et al. Increasing Regulatory T Cells With Interleukin-2 and Interleukin-2 Antibody Complexes Attenuates Lung Inflammation and Heart Failure Progression. Hypertension (Dallas, Tex.:) 68, 114\u2013122 (2016). ) 68, 114\u2013122 (2016). (1979). https:\/\/doi.org\/10.1161\/hypertensionaha.116.07084","DOI":"10.1161\/hypertensionaha.116.07084"},{"key":"6835_CR18","doi-asserted-by":"publisher","first-page":"1503","DOI":"10.1681\/asn.2013070718","volume":"24","author":"YM Wang","year":"2013","unstructured":"Wang, Y. M. & Alexander, S. I. IL-2\/anti-IL-2 complex: a novel strategy of in vivo regulatory T cell expansion in renal injury. J. Am. Soc. Nephrology: JASN. 24, 1503\u20131504. https:\/\/doi.org\/10.1681\/asn.2013070718 (2013).","journal-title":"J. Am. Soc. Nephrology: JASN"},{"key":"6835_CR19","doi-asserted-by":"publisher","first-page":"305","DOI":"10.1111\/imm.12008","volume":"137","author":"SY Lee","year":"2012","unstructured":"Lee, S. Y. et al. Interleukin-2\/anti-interleukin-2 monoclonal antibody immune complex suppresses collagen-induced arthritis in mice by fortifying interleukin-2\/STAT5 signalling pathways. Immunology 137, 305\u2013316. https:\/\/doi.org\/10.1111\/imm.12008 (2012).","journal-title":"Immunology"},{"key":"6835_CR20","doi-asserted-by":"publisher","first-page":"6942","DOI":"10.4049\/jimmunol.181.10.6942","volume":"181","author":"MS Wilson","year":"2008","unstructured":"Wilson, M. S. et al. Suppression of murine allergic airway disease by IL-2:anti-IL-2 monoclonal antibody-induced regulatory T cells. J. Immunol. 181, 6942\u20136954. https:\/\/doi.org\/10.4049\/jimmunol.181.10.6942 (2008).","journal-title":"J. Immunol."},{"key":"6835_CR21","doi-asserted-by":"publisher","first-page":"e0146245","DOI":"10.1371\/journal.pone.0146245","volume":"11","author":"B Mahr","year":"2016","unstructured":"Mahr, B. et al. IL-2\/\u03b1-IL-2 complex treatment cannot be substituted for the adoptive transfer of regulatory T cells to promote bone marrow engraftment. PLoS One. 11, e0146245. https:\/\/doi.org\/10.1371\/journal.pone.0146245 (2016).","journal-title":"PLoS One"},{"key":"6835_CR22","doi-asserted-by":"publisher","first-page":"7083","DOI":"10.1073\/pnas.1620835114","volume":"114","author":"G Whitehouse","year":"2017","unstructured":"Whitehouse, G. et al. IL-2 therapy restores regulatory T-cell dysfunction induced by calcineurin inhibitors. Proc. Natl. Acad. Sci. U S A. 114, 7083\u20137088. https:\/\/doi.org\/10.1073\/pnas.1620835114 (2017).","journal-title":"Proc. Natl. Acad. Sci. U S A"},{"key":"6835_CR23","doi-asserted-by":"publisher","first-page":"1383","DOI":"10.1038\/s41467-023-36924-z","volume":"14","author":"Y Yamada","year":"2023","unstructured":"Yamada, Y. et al. Biased IL-2 signals induce Foxp3-rich pulmonary lymphoid structures and facilitate long-term lung allograft acceptance in mice. Nat. Commun. 14, 1383. https:\/\/doi.org\/10.1038\/s41467-023-36924-z (2023).","journal-title":"Nat. Commun."},{"key":"6835_CR24","doi-asserted-by":"publisher","first-page":"1214","DOI":"10.1016\/j.healun.2019.07.006","volume":"38","author":"D Nakajima","year":"2019","unstructured":"Nakajima, D. et al. Mesenchymal stromal cell therapy during ex vivo lung perfusion ameliorates ischemia-reperfusion injury in lung transplantation. J. Heart Lung Transpl. 38, 1214\u20131223. https:\/\/doi.org\/10.1016\/j.healun.2019.07.006 (2019).","journal-title":"J. Heart Lung Transpl."},{"key":"6835_CR25","doi-asserted-by":"publisher","first-page":"757","DOI":"10.1089\/hum.2016.070","volume":"28","author":"TN Machuca","year":"2017","unstructured":"Machuca, T. N. et al. Safety and efficacy of ex vivo donor lung adenoviral IL-10 gene therapy in a large animal lung transplant survival model. Hum. Gene Ther. 28, 757\u2013765. https:\/\/doi.org\/10.1089\/hum.2016.070 (2017).","journal-title":"Hum. Gene Ther."},{"key":"6835_CR26","doi-asserted-by":"publisher","first-page":"1431","DOI":"10.1056\/NEJMoa1014597","volume":"364","author":"M Cypel","year":"2011","unstructured":"Cypel, M. et al. Normothermic ex vivo lung perfusion in clinical lung transplantation. N. Engl. J. Med. 364, 1431\u20131440. https:\/\/doi.org\/10.1056\/NEJMoa1014597 (2011).","journal-title":"N. Engl. J. Med."},{"key":"6835_CR27","doi-asserted-by":"publisher","first-page":"102994","DOI":"10.1016\/j.ebiom.2020.102994","volume":"60","author":"TJY Ku","year":"2020","unstructured":"Ku, T. J. Y. et al. Ex-vivo delivery of monoclonal antibody (Rituximab) to treat human donor lungs prior to transplantation. EBioMedicine 60, 102994. https:\/\/doi.org\/10.1016\/j.ebiom.2020.102994 (2020).","journal-title":"EBioMedicine"},{"key":"6835_CR28","doi-asserted-by":"publisher","unstructured":"Miyamoto, E. et al. Ex vivo delivery of regulatory T-cells for control of alloimmune priming in the donor lung. Eur. Respiratory Journal: Official J. Eur. Soc. Clin. Respiratory Physiol. 59 https:\/\/doi.org\/10.1183\/13993003.00798-2021 (2022).","DOI":"10.1183\/13993003.00798-2021"},{"key":"6835_CR29","doi-asserted-by":"publisher","first-page":"1229","DOI":"10.1016\/j.healun.2007.10.017","volume":"26","author":"S Stewart","year":"2007","unstructured":"Stewart, S. et al. Revision of the 1996 working formulation for the standardization of nomenclature in the diagnosis of lung rejection. J. Heart Lung Transpl. 26, 1229\u20131242. https:\/\/doi.org\/10.1016\/j.healun.2007.10.017 (2007).","journal-title":"J. Heart Lung Transpl."},{"key":"6835_CR30","doi-asserted-by":"publisher","unstructured":"Fuhrmann, F. et al. Adequate immune response ensured by binary IL-2 and graded CD25 expression in a murine transfer model. Elife 5 https:\/\/doi.org\/10.7554\/eLife.20616 (2016).","DOI":"10.7554\/eLife.20616"},{"key":"6835_CR31","doi-asserted-by":"publisher","first-page":"263","DOI":"10.1038\/16717","volume":"397","author":"A Hutloff","year":"1999","unstructured":"Hutloff, A. et al. ICOS is an inducible T-cell co-stimulator structurally and functionally related to CD28. Nature 397, 263\u2013266. https:\/\/doi.org\/10.1038\/16717 (1999).","journal-title":"Nature"},{"key":"6835_CR32","doi-asserted-by":"publisher","first-page":"5035","DOI":"10.4049\/jimmunol.165.9.5035","volume":"165","author":"AJ McAdam","year":"2000","unstructured":"McAdam, A. J. et al. Mouse inducible costimulatory molecule (ICOS) expression is enhanced by CD28 costimulation and regulates differentiation of CD4\u2009+\u2009T cells. J. Immunol. 165, 5035\u20135040. https:\/\/doi.org\/10.4049\/jimmunol.165.9.5035 (2000).","journal-title":"J. Immunol."},{"key":"6835_CR33","doi-asserted-by":"publisher","first-page":"51","DOI":"10.1084\/jem.20081242","volume":"206","author":"F Cruz-Guilloty","year":"2009","unstructured":"Cruz-Guilloty, F. et al. Runx3 and T-box proteins cooperate to Establish the transcriptional program of effector CTLs. J. Exp. Med. 206, 51\u201359. https:\/\/doi.org\/10.1084\/jem.20081242 (2009).","journal-title":"J. Exp. Med."},{"key":"6835_CR34","doi-asserted-by":"publisher","first-page":"1924","DOI":"10.1126\/science.1122927","volume":"311","author":"O Boyman","year":"2006","unstructured":"Boyman, O., Kovar, M., Rubinstein, M. P., Surh, C. D. & Sprent, J. Selective stimulation of T cell subsets with antibody-cytokine immune complexes. Science 311, 1924\u20131927. https:\/\/doi.org\/10.1126\/science.1122927 (2006).","journal-title":"Science"},{"key":"6835_CR35","doi-asserted-by":"publisher","first-page":"614","DOI":"10.1038\/s41577-022-00680-w","volume":"22","author":"R Hernandez","year":"2022","unstructured":"Hernandez, R., P\u00f5der, J., LaPorte, K. M. & Malek, T. R. Engineering IL-2 for immunotherapy of autoimmunity and cancer. Nat. Rev. Immunol. 22, 614\u2013628. https:\/\/doi.org\/10.1038\/s41577-022-00680-w (2022).","journal-title":"Nat. Rev. Immunol."},{"key":"6835_CR36","doi-asserted-by":"publisher","first-page":"458","DOI":"10.1016\/j.immuni.2008.12.022","volume":"30","author":"N Zhang","year":"2009","unstructured":"Zhang, N. et al. Regulatory T cells sequentially migrate from inflamed tissues to draining lymph nodes to suppress the alloimmune response. Immunity 30, 458\u2013469. https:\/\/doi.org\/10.1016\/j.immuni.2008.12.022 (2009).","journal-title":"Immunity"},{"key":"6835_CR37","doi-asserted-by":"publisher","first-page":"167","DOI":"10.1016\/S0022-5223(19)33753-5","volume":"106","author":"R Ruggiero","year":"1993","unstructured":"Ruggiero, R. et al. Reestablishment of lymphatic drainage after canine lung transplantation. J. Thorac. Cardiovasc. Surg. 106, 167\u2013171 (1993).","journal-title":"J. Thorac. Cardiovasc. Surg."},{"key":"6835_CR38","doi-asserted-by":"publisher","first-page":"1909","DOI":"10.1111\/ajt.17023","volume":"22","author":"A Habertheuer","year":"2022","unstructured":"Habertheuer, A. et al. Donor extracellular vesicle trafficking via the pleural space represents a novel pathway for allorecognition after lung transplantation. Am. J. Transpl. 22, 1909\u20131918. https:\/\/doi.org\/10.1111\/ajt.17023 (2022).","journal-title":"Am. J. Transpl."},{"key":"6835_CR39","doi-asserted-by":"publisher","first-page":"10297","DOI":"10.3389\/ti.2022.10297","volume":"35","author":"MM Lapp","year":"2022","unstructured":"Lapp, M. M. et al. Modeling the potential of Treg-Based therapies for transplant rejection: effect of dose, timing, and accumulation site. Transpl. Int. 35, 10297. https:\/\/doi.org\/10.3389\/ti.2022.10297 (2022).","journal-title":"Transpl. Int."},{"key":"6835_CR40","doi-asserted-by":"publisher","first-page":"793","DOI":"10.1016\/j.drudis.2021.10.012","volume":"27","author":"J Van Hoeck","year":"2022","unstructured":"Van Hoeck, J., Vanhove, C., De Smedt, S. C. & Raemdonck, K. Non-invasive cell-tracking methods for adoptive T cell therapies. Drug Discov Today. 27, 793\u2013807. https:\/\/doi.org\/10.1016\/j.drudis.2021.10.012 (2022).","journal-title":"Drug Discov Today"},{"key":"6835_CR41","doi-asserted-by":"publisher","first-page":"2945","DOI":"10.1111\/ajt.14415","volume":"17","author":"S Chandran","year":"2017","unstructured":"Chandran, S. et al. Polyclonal regulatory T cell therapy for control of inflammation in kidney transplants. Am. J. Transpl. 17, 2945\u20132954. https:\/\/doi.org\/10.1111\/ajt.14415 (2017).","journal-title":"Am. J. Transpl."},{"key":"6835_CR42","doi-asserted-by":"publisher","first-page":"761","DOI":"10.1097\/TP.0b013e31827afb0f","volume":"95","author":"O Brugiere","year":"2013","unstructured":"Brugiere, O. et al. Lung transplantation in patients with pretransplantation donor-specific antibodies detected by luminex assay. Transplantation 95, 761\u2013765. https:\/\/doi.org\/10.1097\/TP.0b013e31827afb0f (2013).","journal-title":"Transplantation"},{"key":"6835_CR43","doi-asserted-by":"publisher","first-page":"1562","DOI":"10.1111\/ajt.15787","volume":"20","author":"A Sicard","year":"2020","unstructured":"Sicard, A. et al. Donor-specific chimeric antigen receptor Tregs limit rejection in Naive but not sensitized allograft recipients. Am. J. Transplantation: Official J. Am. Soc. Transplantation Am. Soc. Transpl. Surg. 20, 1562\u20131573. https:\/\/doi.org\/10.1111\/ajt.15787 (2020).","journal-title":"Am. J. Transplantation: Official J. Am. Soc. Transplantation Am. Soc. Transpl. Surg."},{"key":"6835_CR44","doi-asserted-by":"publisher","first-page":"19954","DOI":"10.1073\/pnas.0704397104","volume":"104","author":"J Yang","year":"2007","unstructured":"Yang, J. et al. Allograft rejection mediated by memory T cells is resistant to regulation. Proc. Natl. Acad. Sci. U S A. 104, 19954\u201319959. https:\/\/doi.org\/10.1073\/pnas.0704397104 (2007).","journal-title":"Proc. Natl. Acad. Sci. U S A"},{"key":"6835_CR45","doi-asserted-by":"publisher","first-page":"33","DOI":"10.1080\/08941930701834114","volume":"21","author":"W Zhai","year":"2008","unstructured":"Zhai, W. et al. Simplified rat lung transplantation by using a modified cuff technique. J. Invest. Surg. 21, 33\u201337. https:\/\/doi.org\/10.1080\/08941930701834114 (2008).","journal-title":"J. Invest. Surg."},{"key":"6835_CR46","doi-asserted-by":"publisher","first-page":"390","DOI":"10.1016\/j.healun.2007.01.018","volume":"26","author":"M Hirschburger","year":"2007","unstructured":"Hirschburger, M. et al. Lung transplantation in the Fischer 344\u2013>Wistar Kyoto rat strain combination is not suitable to study bronchiolitis obliterans. J. Heart Lung Transpl. 26, 390\u2013398. https:\/\/doi.org\/10.1016\/j.healun.2007.01.018 (2007).","journal-title":"J. Heart Lung Transpl."},{"key":"6835_CR47","doi-asserted-by":"publisher","first-page":"999","DOI":"10.1007\/BF00309961","volume":"26","author":"Y Sano","year":"1996","unstructured":"Sano, Y., Maruyama, S., Aoe, M., Date, H. & Shimizu, N. Effect of a single injection of high-dose FK506 on lung transplantation in rats. Surg. Today. 26, 999\u20131005 (1996).","journal-title":"Surg. Today"}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-06835-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-06835-8","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-06835-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,7,2]],"date-time":"2025-07-02T01:43:09Z","timestamp":1751420589000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-06835-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,7,2]]},"references-count":47,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["6835"],"URL":"https:\/\/doi.org\/10.1038\/s41598-025-06835-8","relation":{"references":[{"id-type":"doi","id":"10.1016\/j.healun.2017.07.016","asserted-by":"subject"}]},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,7,2]]},"assertion":[{"value":"28 January 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"11 June 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"2 July 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}},{"value":"M.C. and S.K. are co-founders of Perfusix Canada and Scientific Advisors to Lung Bioengineering. S.K. is CMO of Traferox Technologies. University Health Network has a patent filed and pending for technologies related to donor organ modification, on which S.J., M.C., M.L., and S.K. are inventors.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Disclosure"}}],"article-number":"22897"}}